Brands: Norditropin · Omnitrope · Somatropin
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Novo Nordisk | unknown | 8 | SUPPLYING |
| Sandoz Inc | generic | 4 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Somatropin Injection — reported in shortage by Novo Nordisk, Inc.. Therapeutic category: Endocrinology/Metabolism.
Somatropin Injection — reported in shortage by Novo Nordisk, Inc.. Therapeutic category: Endocrinology/Metabolism.
Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step — Recalling firm: Novo Nordisk Inc — Nationwide
